Vivid Dx
Rapid infectious disease testing helping hospitals identify pathogens and guide antibiotic decisions
$15MSeed
Role not disclosedLoading investors…
Activity from announced rounds
Rapid infectious disease testing helping hospitals identify pathogens and guide antibiotic decisions
AI-driven continuous care platform for autoimmune disease and other complex chronic conditions
An agricultural biotechnology company focused on discovering novel mode of action herbicides
Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients
Uses Causal AI to reformulate complex small-molecule drugs
Pitching Oxford Science Enterprises? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room